Skip to main content
. 2021 Jun 2;11(6):e048808. doi: 10.1136/bmjopen-2021-048808

Table 3.

Within-group and between-group responses of the secondary outcome measures to the intervention from visit 1 to visit 2

Outcome Intervention Control
n Within-group difference n Within-group difference
∆ 6MWT (m) 9 6 (−16, 45) 8 −17 (−74, 4)
∆ SPPB 9 0 (−1, 1) 8 0 (0, 0)
∆ Four-metre gait speed (m/s) 9 0.03 (0.01, 0.06) 8 −0.04 (−0.09, 0.03)
∆ QMVC (kg) 9 −0.1 (−1.9, 2.5) 8 −0.2 (−1.7, 2.0)
∆ Rectus femoris cross-sectional area (mm2) 9 18.0 (−32.6, 48.3) 8 16.0 (−50.6, 33.0)
∆ KBILD—psychological 9 5.9 (−3.4, 12.8) 9 0 (−7.2, 9.6)
∆ KBILD—breathlessness and activities 9 9.3 (−7.8, 13.8) 9 0 (−8.4, 13.5)
∆ KBILD—chest symptoms 9 9.7 (−5.9, 16.7) 9 9.7 (−5.9, 22.9)
∆ KBILD—total score 9 2.7 (−0.2, 7.4) 9 0.1 (−2.2, 3.9)
∆ LCADL—self-care 9 −1.0 (−2.0, 0.0) 9 1.0 (−0.5, 1.5)
∆ LCADL—domestic 9 1.0 (−3.0, 4.5) 9 −1.0 (−3.0, −5.0)
∆ LCADL—physical 9 0.0 (−0.5, 0.5) 9 0.0 (−1.0, 1.5)
∆ LCADL—leisure 9 0.0 (−1.0, 1.0) 9 0.0 (−1.0, 1.5)
∆ LCADL—total score 9 0.0 (−5.0, 2.0) 9 4.0 (−3.0, 10.0)
∆ Daily step count 5 −270 (−504, 877) 5 −740 (−2026, −230)
∆ Daily minutes spent in moderate-intensity PA 5 −3 (−20, 4) 5 −19 (−51, −5)
∆ Daily minutes spent in light-intensity PA 5 24 (5, 71) 5 −39 (−65, 15)
∆ Daily minutes spent sedentary 5 −40 (−58, −21) 5 54 (22, 86)

Data reported as median (25th centile, 75th centile) difference.

KBILD domains and total score: range 0–100; higher scores indicate better health-related quality of life.

LCADL range: self-care: 0–20; domestic: 0–30; physical: 0–10; leisure: 0–15; total: 0–75; higher scores indicate greater impact on activities of daily living (ADL) performance.

KBILD, King’s Brief Interstitial Lung Disease questionnaire; LCADL, London Chest Activities of Daily Living questionnaire; 6MWT, 6 min walk test; PA, physical activity; QMVC, quadriceps maximum voluntary contraction; SPPB, Short Physical Performance Battery.